Cell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cells

被引:136
|
作者
Bobardt, Michael D.
Chatterji, Udayan
Selvarajah, Sugan A.
Van der Schueren, Bernadette
David, Guido
Kahn, Bruce
Gallay, Philippe A.
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[2] Katholieke Univ Leuven VIB, Ctr Human Genet, B-3000 Louvain, Belgium
[3] Flanders Interuniv Inst Biotechnol, B-3000 Louvain, Belgium
[4] Scripps Clin, Dept Obstet & Gynecol, La Jolla, CA 92037 USA
关键词
D O I
10.1128/JVI.01303-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Although the transport of human immunodeficiency virus type 1 (HIV-1) through the epithelium is critical for HIV-1 colonization, the mechanisms controlling this process remain obscure. In the present study, we investigated the transcellular migration of HIV-1 as a cell-free virus through primary genital epithelial cells (PGECs). The absence of CD4 on PGECs implicates an unusual entry pathway for HIV-1. We found that syndecans are abundantly expressed on PGECs and promote the initial attachment and subsequent entry of HIV-1 through PGECs. Although CXCR4 and CCR5 do not contribute to HIV-1 attachment, they enhance viral entry and transcytosis through PGECs. Importantly, HIV-1 exploits both syndecans and chemokine receptors to ensure successful cell-free transport through the genital epithelium. HIV-1-syndecan interactions rely on specific residues in the V3 of gp120 and specific sulfations within syndecans. We found no obvious correlation between coreceptor usage and the capacity of the virus to transcytose. Since viruses isolated after sexual transmission are mainly R5 viruses, this suggests that the properties conferring virus replication after transmission are distinct from those conferring cell-free virus transcytosis through the genital epithelium. Although we found that cell-free HIV-1 crosses PGECs as infectious particles, the efficiency of transcytosis is extremely poor (less than 0.02% of the initial inoculum). This demonstrates that the genital epithelium serves as a major barrier against HIV-1. Although one cannot exclude the possibility that limited passage of cell-free HIV-1 transcytosis through an intact genital epithelium occurs in vivo, it is likely that the establishment of infection via cell-free HIV-1 transmigration is a rare event.
引用
收藏
页码:395 / 405
页数:11
相关论文
共 50 条
  • [41] REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN PRIMARY CULTURED PLACENTAL CELLS
    MANO, H
    CHERMANN, JC
    RESEARCH IN VIROLOGY, 1991, 142 (2-3): : 95 - 104
  • [42] Cyclosporine increases human immunodeficiency virus type 1 vector transduction of primary mouse cells
    Noser, Josh A.
    Towers, Greg J.
    Sakuma, Ryuta
    Dumont, Jean-Maurice
    CollinS, Mary K. L.
    Ikeda, Yasuhiro
    JOURNAL OF VIROLOGY, 2006, 80 (15) : 7769 - 7774
  • [43] Secretory leukocyte protease inhibitor inhibits infection of monocytes and lymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-associated virus across tight epithelial barriers
    Hocini, H
    Becquart, P
    Bouhlal, H
    Adle-Biassette, H
    Kazatchkine, MD
    Bélec, L
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2000, 7 (03) : 515 - 518
  • [44] Cervical human immunodeficiency virus type 1 shedding is associated with genital β-chemokine secretion
    Iversen, AKN
    Fugger, L
    Eugen-Olsen, J
    Balslev, U
    Jensen, T
    Wahl, S
    Gerstoft, J
    Mullins, JI
    Skinhoj, P
    JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (05): : 1334 - 1342
  • [45] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEROCONVERSION IN WOMEN WITH GENITAL ULCERS
    PLOURDE, PJ
    PEPIN, J
    AGOKI, E
    RONALD, AR
    OMBETTE, J
    TYNDALL, M
    CHEANG, M
    NDINYAACHOLA, JO
    DCOSTA, LJ
    PLUMMER, FA
    JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (02): : 313 - 317
  • [46] Epstein-Barr Virus Transcytosis through Polarized Oral Epithelial Cells
    Tugizov, Sharof M.
    Herrera, Rossana
    Palefsky, Joel M.
    JOURNAL OF VIROLOGY, 2013, 87 (14) : 8179 - 8194
  • [47] Human immunodeficiency virus type 1 (HIV-1) integration: a potential target for microbicides to prevent cell-free or cell-associated HIV-1 infection
    Terrazas-Aranda, Katty
    Van Herrewege, Yven
    Hazuda, Daria
    Lewi, Paul
    Costi, Roberta
    Di Santo, Roberto
    Cara, Andrea
    Vanham, Guido
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (07) : 2544 - 2554
  • [48] Human immunodeficiency virus type 1 (HIV-1) infection and transcytosis activity of a HIV-1 susceptible clone from HeLa cell
    Morizono, K
    Harada, S
    MICROBIOLOGY AND IMMUNOLOGY, 1998, 42 (04) : 313 - 320
  • [49] Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women
    Rasheed, S
    Li, ZL
    Xu, D
    Kovacs, A
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 175 (01) : 122 - 130
  • [50] Primary infection by type 1 human immunodeficiency virus: Diagnosis and prognosis
    Vanhems, P
    Beaulieu, R
    POSTGRADUATE MEDICAL JOURNAL, 1997, 73 (861) : 403 - 408